Nabeela Syed flips the Illinois seat Republicans spent a record sum to keep 
Court-martial proceedings begin against two Navy officers over INS Brahmaputra capsize 
Cabinet grants Agniveers two more years and a wider route into regular forces 
Zverev’s No. 1 debut ends in straight sets: what the Musetti loss actually says 
SSC CGL answer key 2026 gives candidates a response sheet to audit, not a result to trust 
GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor
? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon Award for Disease Elimination ?...
Leading Cosmetics Brand Pula Enters the Chinese Market
TOKYO, JAPAN - Media OutReach - 13 December 2021 - Recently, Pula, a well-known Japanese cosmetics brand for children, has enters the...
Understanding the Hehe Culture and A Community of Shared Future for Mankind in Taizhou, Zhejiang
TAIZHOU, China--(BUSINESS WIRE)--Themed “Hehe Culture and A Community of Shared Future for Mankind”, the 2021 Hehe Culture Global Forum was...
BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting
BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with chronic lymphocytic leukemia Consistent efficacy...
Digital Entertainment Leadership Forum’s flagship event on second day
APRU MetaGame Conference focused on education, talent, and the future of esports HONG KONG SAR - Media OutReach - 12...
Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory ATL Orphan Drug Designation granted...
BeiGene Presents Updated Safety and Efficacy Findings on BRUKINSA (zanubrutinib) in BTK Inhibitor-Intolerant Patients with Relapsed or Refractory B-Cell Malignancies
Follow-up results from Phase 2 trial suggested intolerable adverse events leading to discontinuation of previous BTK inhibitor therapy were unlikely...
Rare Element Resources Announces Results of Oversubscribed Rights Offering of Common Shares
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to report that its previously announced...
SunMirror AG: Expanding the Team to Support the Execution of the Growth Strategy into Critical Raw Materials
ZUG, SWITZERLAND - EQS Newswire - 11 December 2021 - SunMirror AG ("SunMirror", "the Company"; Vienna Stock Exchange: ROR1; Frankfurt Stock...
CTO Realty Growth Completes Sale of the Remaining Daytona Beach Land Within Its Land Joint Venture
DAYTONA BEACH, Fla., Dec. 10, 2021 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today...
Pony.ai Begins Autonomous Driving Public Road Testing in Shenzhen
Pony.ai now has autonomous driving public road testing permits in all four Tier-1 cities in China, making it one of...
Global Semiconductor Intellectual Property Market Research Report 2021 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Semiconductor Intellectual Property Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Global Semiconductor Intellectual Property Market Research Report 2021 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Semiconductor Intellectual Property Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Global High Throughput Screening Market Outlook to 2030 with Focus on Asia-Pacific – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global & Asia Pacific High Throughput Screening Market Outlook 2030" report has been added to ResearchAndMarkets.com's offering. The...
Notice of Extraordinary General Meeting in Karolinska Development AB (publ)
The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”) are invited to the Extraordinary...
